The number and type of metabolic risk factors correlated with outcomes, furthermore, severe CKD and prior CVD were stronger drivers of adverse outcomes than metabolic dysfunction.<h4>Conclusion</h4>CKM staging stratifies risk in the general population. This evidence concerns the gene CKM and chronic kidney disease.